Legend Biotech (LEGN) Shares Outstanding (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Shares Outstanding (Entity) data on file, last reported at $371.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 0.93% year-over-year to $371.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $371.5 million (up 0.93% YoY) and the FY2025 annual result came in at $369.9 million, up 0.7% from the prior year.
• Shares Outstanding (Entity) held at $371.5 million in Q1 2026, from $369.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $371.5 million in Q1 2026 to a low of $308.7 million in Q1 2022.
• A 5-year average of $352.7 million and a median of $364.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) climbed 17.29% — and 2025, when it climbed 0.68%.
• Tracing LEGN's Shares Outstanding (Entity) over 5 years: stood at $330.1 million in 2022, then climbed by 10.2% to $363.8 million in 2023, then climbed by 0.96% to $367.3 million in 2024, then rose by 0.7% to $369.9 million in 2025, then rose by 0.43% to $371.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $371.5 million (Q1 2026), $369.9 million (Q4 2025), and $369.4 million (Q3 2025), per Business Quant data.